Validation of nomogram in patients with high-grade astrocytoma
high-grade astrocytoma
The AUC values of 3-year and 5-year survival rates of patients with high-grade astrocytoma training set were 0.814 and 0.806, respectively, and the AUC values of 3-year and 5-year survival rates of patients in the validation set were 0.802 and 0.823, respectively (Fig. ROC curves of 3-year and 5-year survival prediction in patients with high-grade astrocytoma (3-year and 5-year survival calibration curves for patients with high-grade astrocytoma (